Search International and National Patent Collections
|1. (WO2018220446) TRIPLE COMBINATION ANTIBODY THERAPIES|
|Title:||TRIPLE COMBINATION ANTIBODY THERAPIES|
The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti- PD-L1 antibodies.